The US court overseeing multidistrict opioid litigation has shot down requests by manufacturers to limit the amount of information they must turn over in discovery, ordering the production of data on generic as well as branded products going back one year prior to their launch date. Defendants also must produce data that was previously made available in personal injury cases.
Special Master David Cohen issued a June 30 discovery ruling on several disputed issues. The ruling provides insight into...







